Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin... see more

Bullboard (TSXV:ARCH)

View:
User Avatar Image
(57)
•••
  • Viking2233X
Post by Viking2233on Nov 30, 2025 12:12pm

Algo Flip

I would assume we must be very close to the bottom and finished consollidating here at the $1.00. The Algo's have achieved their pound of flesh and it will be hard for them to profit much from ...more  
User Avatar Image
(57)
•••
  • Viking2233X
Post by Viking2233on Nov 21, 2025 10:53am

Current Share Price

Is there sny bonafide reason(s) why share price should be higher? Absolutely! We have two active phase 2 trials with one trial already 50% complete with zero adverse reactions reported. This ...more  
User Avatar Image
(57)
•••
  • Viking2233X
Post by Viking2233on Nov 14, 2025 9:41am

Business Plan

What is the game plan, does Arch have a business plan that will drive buyers into the market?   That is a bonafide question. Two years ago they announced phase 2 AkI trial with 6 sites in ...more  
User Avatar Image
(11)
•••
  • TheBearInTheWoodsX
Post by TheBearInTheWoodson Nov 11, 2025 10:32am

New Shareholders or New Management?

I understand that management wants me to sell my shares because I've become a "squeaky wheel" by raising concerns. It's strange how the stock price has dropped 80% from its highs ...more  
User Avatar Image
(57)
•••
  • Viking2233X
Post by Viking2233on Oct 23, 2025 7:28am

Recent Selloff

So the recent sell off of a couple million shares by desparate shareholder has exposed some cracks in Arch Managements Business Model. The biggest issue is the lack of liquidity and lack of buyers ...more  
Comment by Bertie20on Oct 22, 2025 8:01am

RE:NEW 52 Week Low - Where is Management?

I have held these for quite a long time, and rarely check in. Absolutely shocked at the share price. Is it going bust?
User Avatar Image
(11)
•••
  • TheBearInTheWoodsX
Post by TheBearInTheWoodson Oct 21, 2025 2:03pm

NEW 52 Week Low - Where is Management?

Same management = No respectful communication with Shareholders
User Avatar Image
(11)
•••
  • TheBearInTheWoodsX
Post by TheBearInTheWoodson Oct 20, 2025 11:26am

NEW 52 Week Low - Where is Management?

These guys need to realize that Arch is a public company
User Avatar Image
(57)
•••
  • Viking2233X
Comment by Viking2233on Oct 17, 2025 4:01pm

RE:No Response From ARCH Management

Sir you have valid concerns and points. I have said in the past this company has real bonafide science but their operational decisions are questionable. Arch is a public traded company but management ...more  
User Avatar Image
(11)
•••
  • TheBearInTheWoodsX
Post by TheBearInTheWoodson Oct 17, 2025 2:16pm

No Response From ARCH Management

Dear Arch Biopartners Management, I am writing to follow up on concerns I raised a month ago, which have gone unaddressed, while the company’s share price has declined by over 50%, reflecting ...more  
User Avatar Image
(4)
•••
  • RiverfolkX
Post by Riverfolkon Oct 15, 2025 1:57pm

Material Achievements of Arch Biopartners Since April 2020

Material Achievements of Arch Biopartners Since April 2020 at .98   April 2020**: Completed Phase I human trial for LSALT peptide (Metablok), confirming safety and tolerability in 52 healthy ...more  
User Avatar Image
(2)
•••
  • williepokerX
Post by williepokeron Oct 01, 2025 2:01pm

5 Year Chart - looking bullish

Thoughts?  Where's Riverfolk?
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

Podcasts